Study Details
Full Title
A PHASE 3, MULTICENTER, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE REGN7508, A FACTOR XI MONOCLONAL ANTIBODY, VERSUS ACETYLSALICYLIC ACID FOR PROPHYLAXIS OF SYMPTOMATIC VENOUS THROMBOEMBOLISM AFTER ELECTIVE TOTAL KNEE ARTHROPLASTY (ROXI-ASPEN)
Principal Investigator
Thorsten
Seyler
Protocol Number
PRO00119643
NCT ID
NCT07213778
Phase
III
Enrollment Status
Open to Enrollment